ReviewCell fate regulation by chromatin ADP-ribosylation
Section snippets
NAD+ and ADP-ribosylation
Nicotinamide adenine dinucleotide (NAD+) is a main component of cellular redox reactions and thus an important player in energy metabolism. Upon accepting two electrons and a proton, NAD+ forms the reducing agent NADH, which fuels the mitochondrial electron transport chain [1]. Additional roles of NAD+, which include ADP-ribosylation, are emerging and are reviewed in [2]. ADP-ribosylation is an evolutionarily conserved posttranslational modification found in all living cells (with the exception
Chromatin ADP-ribosylation in development and differentiation
In this chapter, several aspects on how ADP-ribosylation affects development and differentiation are discussed. The current literature and proposed mechanisms and functions of chromatin ADP-ribosylation in development and differentiation are summarized in Table 1.
Chromatin aspects
Even though proposed almost 50 years ago, the simple and elegant Waddington model of cell differentiation still holds true to date [88]. In his model, Waddington proposes a pluripotent cell to be a marble on top of a hill; the marble takes different choices as it rolls down the hill and these choices become rarer, the further downhill the marble rolls. The final destination at the bottom of the hill represents the full differentiation of a cell. This simple model nicely illustrates how a cell
Acknowledgements
The authors would like to thank Stephan Christen and Deena Leslie Pedrioli (both University of Zurich) for editorial assistance and critical input during the writing. We apologize to all the researchers, whose work could not be included in the review due to space restrictions. Work on ADP-ribosyltransferases in the laboratory of M.O.H is supported by the Swiss National Science Foundation (SNF 310030B_138667, 310030_157019).
References (126)
- et al.
Cell Metab.
(2015) - et al.
Trends Biochem. Sci.
(2010) - et al.
J. Biol. Chem.
(1971) - et al.
Biochem. Biophys. Res. Commun.
(1972) - et al.
J. Biol. Chem.
(2006) - et al.
J. Biol. Chem.
(2000) - et al.
J. Biol. Chem.
(2005) - et al.
Trends Biochem. Sci.
(2012) - et al.
Redox Biol.
(2014) - et al.
Mol. Cell
(2009)
Biochim. Biophys. Acta-Gene Regul. Mech.
Fertil. Steril.
Mech. Dev.
Biochim. Biophys. Acta
Cell
J. Biol. Chem.
J. Biol. Chem.
Free Radic. Biol. Med.
Am. J. Pathol.
Blood
Blood
Cell
J. Biol. Chem.
Cell
J. Biol. Chem.
J. Biol. Chem.
Nat. Rev. Mol. Cell Biol.
Front. Biosci.
Curr. Med. Chem.
Nat. Rev. Mol. Cell Biol.
Nat. Commun.
Proc. Natl. Acad. Sci. U. S. A.
Proc. Natl. Acad. Sci. U. S. A.
Nat. Struct. Mol. Biol.
Nat. Struct. Mol. Biol.
EMBO J.
Science
Nat. Struct. Mol. Biol.
Nat. Struct. Mol. Biol.
Nucleic Acids Res.
Nat. Struct. Mol. Biol.
Proc. Natl. Acad. Sci. U. S. A.
Nature
Genes Dev.
Nat. Cell Biol.
Proc. Natl. Acad. Sci. U. S. A.
Genes Dev.
Nucleic Acids Res.
Biomolecules
EMBO J.
Cited by (23)
Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes
2022, Biomedicine and PharmacotherapyMyoD induces ARTD1 and nucleoplasmic poly-ADP-ribosylation during fibroblast to myoblast transdifferentiation
2021, iScienceCitation Excerpt :To investigate ADPR exclusively during MyoD-dependent transdifferentiation, excluding its contribution to muscle differentiation, hereafter we exclusively focused on the first 24 h after dox treatment (GM1, Figure S1A). Because ARTD1 participates in several differentiation and reprogramming systems (Abplanalp and Hottiger, 2017) but its contribution to transdifferentiation is unknown, we took advantage of the MyoD-induced transdifferentiation system to investigated its expression exclusively in transdifferentiated cells, thus excluding its contribution to differentiation. MyoD+ cells were treated with dox, and protein levels of both ARTD1 and MyoD were analyzed at the single-cell level by quantitative image-based cytometry (QIBC) (Toledo et al., 2013) (Figure 1A).
Poly(ADP-Ribosylation) in Age-Related Neurological Disease
2019, Trends in GeneticsRegulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond
2019, Trends in ImmunologyCitation Excerpt :ADP-ribosylation is an evolutionarily conserved post-translational modification (PTM) that is present in many prokaryotic and in all eukaryotic cells except for yeast [1].
Cell-Based Screening for New PARP Inhibitors Utilizing PARG-Mutated Mouse Embryonic Stem Cells
2023, Methods in Molecular Biology